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Phenotyping placental 
oxygenation in Lgals1 deficient 
mice using 19F MRI
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Marco Foddis1,2, Stefan P. Koch 1,2, Sebastian Temme6, Ulrich Flögel6 & Sandra M. Blois3,4*
Placental hypoperfusion and hypoxia are key drivers in complications during fetal development such 
as fetal growth restriction and preeclampsia. In order to study the mechanisms of disease in mouse 
models, the development of quantitative biomarkers of placental hypoxia is a prerequisite. The goal 
of this exploratory study was to establish a technique to noninvasively characterize placental partial 
pressure of oxygen  (PO2) in vivo in the Lgals1 (lectin, galactoside‑binding, soluble, 1) deficient mouse 
model of preeclampsia using fluorine magnetic resonance imaging. We hypothesized a decrease 
in placental oxygenation in knockout mice. Wildtype and knockout animals received fluorescently 
labeled perfluoro‑5‑crown‑15‑ether nanoemulsion i.v. on day E14‑15 during pregnancy. Placental 
 PO2 was assessed via calibrated 19F MRI saturation recovery  T1 mapping. A gas challenge with varying 
levels of oxygen in breathing air (30%, 60% and 100%  O2) was used to validate that changes in 
oxygenation can be detected in freely breathing, anesthetized animals. At the end of the experiment, 
fluorophore‑coupled lectin was injected i.v. to label the vasculature for histology. Differences in 
 PO2 between breathing conditions and genotype were statistically analyzed with linear mixed‑
effects modeling. As expected, a significant increase in  PO2 with increasing oxygen in breathing 
air was found.  PO2 in Lgals1 knockout animals was decreased but this effect was only present at 
30% oxygen in breathing air, not at 60% and 100%. Histological examinations showed crossing of 
the perfluorocarbon nanoemulsion to the fetal blood pool but the dominating contribution of 19F 
MR signal is estimated at > 70% from maternal plasma based on volume fraction measurements of 
previous studies. These results show for the first time that 19F MRI can characterize oxygenation in 
mouse models of placental malfunction.
Noninvasive examination of the placenta is of utmost importance in order to study pregnancy complications. In 
humans, ultrasound imaging is standard procedure to investigate the fetal and placental health without conferring 
risks to the mother or the unborn child. Ultrasonic examination allows the determination of fetal weight and 
size, inspection of fetal organs, detection of certain malformations or developmental disorders and measure-
ments of motion sequences. Doppler ultrasonography allows studies of blood circulation in the fetus, placenta 
and  uterus1. Magnetic resonance imaging (MRI) is currently indicated in certain maternal conditions such as 
appendicitis, pulmonary embolism, renal colic, and trauma and provides excellent prospects for translational 
 research2–6. MRI of hypoperfusion has been shown to be a marker of intrauterine growth  restriction7 and recent 
advances in pulse sequence design may enable a broader dissemination of placental perfusion MRI for clinical 
studies and  diagnosis8. MRI was also successfully applied to investigate pregnancy in rodent models including 
dynamic contrast-enhanced  MRI9–11, arterial spin labeling of placental  perfusion12, diffusion MR of placental 
compartmental flow  dynamics13, or blood/tissue oxygen level dependent (BOLD/TOLD) MRI of hemoglobin 
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 oxygenation14. A major advantage of small animal MRI is the possibility to follow dynamic processes over time 
in repetitive sessions, which is not possible in histological examinations.
The partial pressure of oxygen  (PO2) is the most relevant parameter for the body’s oxygen sensing  systems15 
and all 1H MR methods (BOLD/TOLD/perfusion MRI) provide only surrogate markers of  PO2. More direct 
techniques such as polarographic electrodes, fiberoptic probes or optical imaging suffer from limited penetra-
tion depth and are invasive for deeper  tissue16. A particularly promising technique for preclinical studies of 
placental blood oxygenation saturation  (SO2) is optoacoustics but it cannot directly assess  PO217–19. Therefore, 
there is a strong need for other spatially-resolved techniques to measure the absolute partial pressure of oxygen 
of the placenta in vivo. Since the fluorine (19F) longitudinal relaxation rate  R1 = 1/T1of several perfluorocarbons 
(PFCs) correlates with  PO2, 19F MRI has been used to study deep tissue oxygenation in animal models of disease 
including tumors, kidney injury or cerebral  hypoperfusion20–25. The investigation of dynamic vascular changes 
and placental perfusion and oxygenation by MRI is a promising opportunity to explore angiogenesis-related 
pregnancy disease.
Pregnancy acts as a cardiac stress model inducing in some cases adverse cardiac events in healthy women 
without any previously known cardiovascular  disease26–28. As a consequence of such cardiac stress 5–7% of all 
pregnancies develop preeclampsia which is associated with hypertension after the 20th week of gestation (with or 
without proteinuria), in conjunction with fetal growth restriction, maternal endothelial dysfunction and chronic 
immune  inflammation29–31. Preeclampsia imposes a maternal increased risk of cardiovascular disease death later 
in life, independent of other measured risk factors. Moreover, preeclampsia is a major underlying cause of late 
fetal and early neonatal  mortality29,30. A poor utero-placenta circulation secondary to inadequate remodeling 
compromises nutrition and oxygenation of the fetus and is associated with fetal growth  restriction29,30.
Among the immunoregulatory and angiogenic factors, galectin-1 (gal-1), a member of a family of carbohy-
drate-binding proteins, has been shown to modulate several processes associated with placentation, promotion of 
maternal tolerance toward fetal antigens and regulation of decidual vascular expansion during the pre-placenta-
tion  period32–34. Blocking gal-1–mediated angiogenesis with anginex, a 33-mer cytokine-like artificial β-peptide, 
results in a spontaneous preeclampsia-like syndrome in mice, mainly by deregulating processes associated with 
good placentation and maternal spiral artery  remodeling35. Consistent with these findings, using gal-1 deficient 
dams we demonstrated the development of a preeclamptic-like phenotype in which mice developed gestational 
hypertension, proteinuria, smaller litters and progressive glomerulosclerosis. In addition to this, gal-1 deficient 
mice also demonstrated endothelial dysfunction, abnormal maternal decidual arteries, increased vascular resist-
ance in the uterine arteries and poor placental  development35.
The goal of this exploratory study was to investigate the potential of 19F MRI to measure placental oxygenation 
after i.v. injection of a Perfluoro-15-crown-5-ether (PFCE) emulsion in the gal-1 deficient Lgals1−/− knockout 
mouse, hypothesizing a  PO2 deficit in this model of preeclampsia.
Results
Method validation by gas challenge. To investigate the effect of increasing levels of  O2 in breathing gas 
on measured  PO2, 1H and 19F acquisitions were repeated under 60%  O2 in 40%  N2O and under 100%  O2 as illus-
trated in Fig. 1. Figure 2 shows typical volumes of interest overlaid on anatomical 1H images along with  T1 fits of 
mean 19F signal-to-noise ratio (SNR) and the final result for mean  PO2 in WT and KO mice at varying oxygen 
levels in breathing air. The shape of the fitted curves varied substantially, which indicated heterogeneity in  PO2 
between animals, between placentas within one animal and between different breathing conditions. Descriptive 
statistics showed an expected increase in SNR on  T1-weighted images (Fig. 3A), a decrease in  T1 (Fig. 3C) and 
increase in  PO2 with increasing oxygen in breathing air, while relative 19F concentration  S0 remained similar. 
Mixed-effects modeling of SNR(TRi, i = 1, 2, 3, 4),  T1 and  PO2 between genotype and percent oxygen in breathing 
air are summarized in Table 1 and confirmed this observation. A significant effect of percent oxygen in breath-
ing air on SNR,  T1 and  PO2 was found, even for SNR at the least  T1-weighting (TR = 5000 ms) indicating an 
expected strong effect of oxygen level on  PO2 in the placenta. The fitted equilibrium signal  S0 = SNR(TR >> T1) is 
a marker of local contrast agent concentration and was neither different between animals nor between breathing 
conditions.   
Figure 1.  Experimental design. Freely breathing Lgals1 WT and KO animals underwent serial MRI at different 
levels of oxygen in breathing air after receiving PFCE emulsion i.v. Fluorophore-coupled lectin was injected at 
the end of the experiment in order to label the vasculature for histological examinations.
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19F MRI of placental  PO2 in preeclampsia mouse model. No effect of genotype was found in any of 
the parameters in the full statistical linear mixed-effects model but a significant interaction between percent 
oxygen and genotype at 30%  O2 in breathing air (Table 1). In line with this, descriptive statistics did not show 
major genotype differences at higher oxygen levels in breathing air (Fig. 3). We further investigated genotype 
differences at 30% oxygen by linear mixed-effects modeling (Table 2). A significant effect of genotype was found 
for  PO2,  T1 and the  T1-weighted images SNR(TR1 = 318 ms) and SNR(TR2 = 719 ms) whereas this effect van-
ished for less  T1-weighting at longer TRs. In Lgals1-knockout mice  PO2 was lower compared to wildtypes (KO: 
38 ± 52 mmHg, WT: 102 ± 35 mmHg, data expressed as estimated mean (ME) ± 95% confidence interval (CI), 
p = 0.016) i.e.  T1 was higher (KO: 2.18 ± 0.43 s, WT: 1.66 ± 0.30 s, ME ± 95%CI, p = 0.020). Accordingly, SNR was 
lower in transgenic animals for  T1-weighted images at lowest TR (TR = 318 ms, KO: 1.26 ± 0.14, WT: 1.45 ± 0.10, 
p = 0.008) and second-lowest TR (TR = 719 ms, KO: 2.12 ± 0.33, WT: 2.57 ± 0.23, ME ± 95%CI, p = 0.009).
Histology. In order to qualitatively assess the distribution of 19F agent in the maternal and fetal blood pool 
and in cells of the placenta, fluorescent microscopy of the maternal blood vessels (fluorophore-coupled lectin, 
green), the 19F agent (Rhodamine, red) and cell nuclei (DAPI, blue) was performed. Figure 4, shows the 19F agent 
labeled with Rhodamine crossed the placental barrier and penetrated the maternal and fetal circulation within 
the labyrinth area of the placenta.
Discussion
So far, most studies on oxygenation 19F MRI have focused on tumors and liver. We hypothesized that the placenta 
is a particularly favorable organ to study with this technique since a large volume fraction consists of maternal 
plasma which can be reached via simple i.v. injection. In a three compartment model (maternal, fetal and tropho-
blast pool), a recent diffusion MRI study estimated the maternal blood volume fraction of the placenta at 64.4% 
(fetal pool: 23.7%, trophoblast pool: 11.9%) and optical imaging confirmed this (~ 70%:30% ratio of maternal:fetal 
blood pool volume)13. In our qualitative histological examinations, we found most fluorescence signal originating 
from maternal blood but some signal was also present in both trophoblast and fetal pool. Although dissociation 
of the fluorophore from PFCE nanoemulsion particles is  possible36, the vesicular patterns of Rhodamine signal 
hints toward true phenomenon of particles crossing the placental barrier. Mechanisms that regulate the transfer of 
nanoparticles across the placenta and fetal circulation include simple difussion, active transport, phagocytosis and 
 endocytosis37,38. Considering the average PFCE nanoparticle size of 100–200 nm, phagocytosis/endocytosis seem 
the most likely route. This hypothesis is supported by the finding that caboxylate-modified polystyrene beads 
with diameters between 20 and 500 nm injected intravenously in pregnant mice accumulated in the placenta via 
trophoblast  uptake39. Taken our histological observations together with the quantitative argument on volume 
fractions, we assume that at least 70% of the contribution to  PO2 in our study originates from maternal plasma. 
The contribution is probably higher since diffusivity in the fetal blood pool is orders of magnitude higher than 
in the other two  compartments13 which further diminishes the fetal 19F MR signal as summarized in Fig. 5. Since 
 PO2 is likely to be different for each of the three compartments, 19F MRI signal fractions could be estimated via 
equilibrium signals  S0maternal,  S0trophoblast,  S0fetal from multiexponential fitting. Adding the assumption of compart-
mental volume fractions from diffusion imaging could dissect the exact amount of PFCE crossing. Although the 
19F MR sensitivity in our study was not sufficient to perform such fine-grained models with 6 fitting parameters 
 (S0 and  T1 per compartment), future gains in SNR will enable these types of analyses.
Figure 2.  Example data from wildtype (WT) and Lgals1−/− knockout (KO) animal. Colorcoded overlay of 
placental volumes of interest on anatomical  T2-weighted MR images. Corresponding mean 19F MRI SNR,  T1 fits 
and calculated relative 19F concentration  S0 and  PO2 in mmHg at different levels of oxygen in breathing air are 
shown for the two placentas marked by dashed lines.
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:2126  | https://doi.org/10.1038/s41598-020-80408-9
www.nature.com/scientificreports/
We assumed a steady state of PFCE concentration in the different compartments of the mouse placenta, which 
is a valid assumption since  S0, a marker of local 19F concentration, was not different between breathing condi-
tions over a period of ~ 1.5 h. During this time, internalization of PFCE nanoparticles by circulating monocytes/
macrophages is very  likely40. There is an oxygen gradient between mitochondria and plasma, which may lead 
to apparently lower PO2 values of intracellular vs. extracellular PFCE. Using oxygen-sensitive microscopy of 
green fluorescence protein, intracellular oxygen gradients were found to be very small in monolayer cell culture 
(~ 0.03 mmHg/µm)41 and we thus did not correct for this source of bias.
Placental  PO2 under normal and pathological conditions. The most relevant outcome parameter 
in pathology of placental circulation is the oxygenation of the fetus. We found lower placental  pO2 in Lgals1 
knockout dams. Due to the low statistical power in our experiments, this finding needs to be confirmed in a 
hypothesis-driven study. Another limitation of the current study is that most  PO2 signal originates from mater-
nal pool, i.e. it provides only an indirect marker of fetal oxygenation. A recent optoacoustic study, however, has 
shown that changes in  SO2 in the feeding maternal artery, the placenta and the fetus are directly correlated dur-
ing a gas  challenge17. The same phenomenon is expected for  PO2in the range of 0–128 mmHg when  PO2 and 
 SO2 are tightly linked through the oxygen dissociation curve (OCD). Under 30%  O2, the  PO2 values found in 
this study in wildtypes (~ 100 mmHg) are higher than those known from optoacoustics under normoxia with 
20% oxygen  (SO2 ~ 50%, i.e.  PO2 ~ 30 mmHg using the OCD). The differences cannot be attributed to the higher 
level of oxygen in breathing air alone. Inaccuracies in the in vitro calibration of  R1 and  PO2, discrepancies in 
anesthesia depth, use of  NO2 in our study and the inability of optoacoustics to capture dissolved oxygen in blood 
present further obstacles in direct comparison of results. For hyperoxia (100%  O2) we show dramatic increases 
in partial pressure of oxygen  (PO2 > 200 mmHg) which can only be explained by a significant amount of dis-
Figure 3.  Descriptive statistics of 19F MRI parameters in Lgals1 wildtype (WT, black circles) and knockout 
(KO, gray circles) placentas at 30%, 60% and 100% oxygen in breathing air. Shown are (A) signal to noise 
ratio on one of the  T1-weighted images, (B) fitted relative 19F concentration  S0, (C) fitted  T1 relaxation time 
and (D) calculated  PO2 ~ 1/T1. Increasing the amount of oxygen in breathing air led to an apparent increase in 
SNR, decrease in  T1 and increase in  PO2 but also an increase in variance. Parameters indicative of decreased 
oxygenation in knockout animals were only obvious at 30% oxygen. Red lines show mean, red and blue areas 
correspond to 95% confidence intervals and standard deviation, respectively.
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solved oxygen. This observation is in line with other studies of maternal arterial  PO2 in sow, mare and  ewe42. 
In addition, besides the phenomenon of dissolved oxygen in blood, PFCs themselves are able to transport gases 
and this effect becomes stronger when breathing high levels of oxygen, a phenomenon which is well described 
in PFC-based therapy of  hypoxia43,44 and could open the field of placental theranostics.
Technical considerations: imaging. The first 19F MRI experiments date back as early as the beginning of 
human 1H MRI in the  1970s45. Paralleling investigations on gas-solving capabilities of PFCs led to the finding of 
a linear response of 19F relaxation rate  R1 to local oxygen concentration of  PFCs45. Despite this long history, low 
sensitivity has limited the widespread use of 19F MRI. This becomes particularly severe for oxygenation 19F MRI 
since introducing the necessary  T1-weighting in images leads to further loss of SNR. Recent technical advances 
in field strength, MR coil design and PFC emulsion synthesis, however, have boosted the field, particularly with 
applications in molecular and cellular  MRI25,36. The experiments of this study were performed at a field strength 
of 7 T using a double-tuned room temperature 40 mm transmit/receive birdcage resonator coil and the robust 
turbo spin echo saturation recovery pulse sequence. Within reasonable 20 min imaging time, we managed to 
acquire sufficient SNR for T1 fitting, albeit at the border of detectability for the highest  T1-weighting. The SNR 
was lower compared to in vitro experiments and this could be explained by motion which is omnipresent when 
imaging the abdomen in vivo. Consequently, our study has several limitations. First, voxel-wise analysis of  PO2 
was not possible due to error propagation in the calculation of  PO2 from  T1. Second, smoothing was necessary 
to improve SNR at loss of resolution. Third, only few T1-weighted images were acquired within reasonable time 
introducing error on the two-parameter fit. These sources of variance and  PO2-unrelated changes of relaxivity 
Table 1.  Linear mixed-effect modeling including all experimental conditions. Tests of fixed effects (factors 
genotype and oxygen level) for  PO2,  T1, SNR and  S0. More detailed statistical parameters including estimates 
can be found in the open data repository.
Parameter Source Numerator df Denominator df F p
PO2
Genotype 1 25.938 1.288 .267
Perc 2 52.556 12.669 3.200E−05
Genotype × perc 2 52.556 5.524 .007
T1
Genotype 1 26.905 .954 .337
Perc 2 54.419 9.525 2.840E−04
Genotype × perc 2 54.419 4.602 .014
SNR(TR1)
Genotype 1 33.850 4.030 .053
Perc 2 62.223 24.476 1.440E−8
Genotype × perc 2 62.223 .830 .441
SNR(TR2)
Genotype 1 34.799 2.928 .096
Perc 2 63.504 18.131 5.900E−7
Genotype × perc 2 63.504 1.480 .235
SNR(TR3)
Genotype 1 33.787 2.510 .122
Perc 2 62.723 6.718 .002
Genotype × perc 2 62.723 .042 .959
SNR(TR4)
Genotype 1 31.454 .477 .495
Perc 2 61.012 4.380 .017
Genotype × perc 2 61.012 .635 .534
S0
Genotype 1 31.086 .055 .816
Perc 2 60.882 2.369 .102
Genotype × perc 2 60.882 1.493 .233
Table 2.  Linear mixed-effect modeling results at 30% oxygen. Tests of fixed effects (factor genotype) for  PO2, 
 T1, SNR and  S0. More detailed statistical parameters including estimates and confidence intervals can be found 
in the open data repository.
Parameter Source Numerator df Denominatordf F p
PO2 Genotype 1 32 6.477 .016
T1 Genotype 1 32 6.041 .020
SNR(TR1) Genotype 1 32.000 7.931 .008
SNR(TR2) Genotype 1 32 7.744 .009
SNR(TR3) Genotype 1 32.000 3.616 .066
SNR(TR4) Genotype 1 32.000 .002 .965
S0 Genotype 1 32 .816 .373
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e.g. due to local field distortions at tissue/air interfaces in the bowel, can account for the physiologically impos-
sible values of  PO2 below 0 or larger 760 mmHg (1 atmosphere) in our data.
Assuming a near-linear relationship of SNR efficiency with field strength (sample-dominant noise), an 
improvement in sensitivity by factor > 2 is to be expected for the currently strongest MRI system at 21.1 T46. 
Our first results with cryogenic coils for mouse brain 19F MRI have shown a similar increase in sensitivity of 
factor ~ 2 to 3 compared to room temperature  coils21,47. A transfer of this technology to abdominal imaging in 
pregnancy is pending but feasible through adaptation of coil geometry. More SNR efficient  T1 mapping such 
as Look-Locker methods are generally more prone to artefacts but should further be explored for abdominal 
19F  MRI48. Finally, the 19F MR signal is limited to maternal blood pool and other, spatially sparse regions of the 
mother. This fact can be used to accelerate imaging using compressed sensing reconstruction. First studies show 
that a decrease of imaging time at identical SNR by factor > 2.5 is possible for point-like sources of  signal49,50. 
Absence of genotype differences were observed for the two higher levels of oxygen in breathing air, so even in 
the current study design, a significant improvement in SNR efficiency by factor 3 reduction in scan time can be 
anticipated when only interested in genotyping. Taken all of these efforts together, an extraordinary gain in SNR 
efficiency up to an order of magnitude seems possible with modified study designs and technology available 
already now or in the near future.
Technical considerations: 19F agent. The investigation of PFC emulsions as blood substitutes resulted 
in toxicological profiling to the level of clinical trials for several compounds such as perfluorooctyl bromide 
(PFOB) or  Perfluorodecalin25. However, most of the clinically approved compounds have less favorable prop-
erties for oxygenation MRI, e.g. complex spectra with multiple resonances (e.g. PFOB), short biological half 
Figure 4.  Representative placental histology images derived from Lgals1WT (upper) and Lgals1KO (lower) 
showing the decidua (Dec) and placenta layers including the Labyrinth. 19F Agent (red) was found in both 
maternal and fetal blood spaces. Fetal circulation is denoted by the asterisks inserts in both Lgals1 WT (upper) 
and Lgals1KO (lower). DAPI counterstained nuclei and DyLight 488 labeled Lycopersicon Esculentum (Tomato) 
Lectin (LEL) was used for imaging vascular structures (endothelial cells). Bars indicate 1000 µm, 100 µm and 
50 µm respectively.
Figure 5.  (A) Illustration of the mouse placenta and its compartments after i.v. injection of PFCE 
nanoemulsion. (B) Summarizing qualitative and quantitative arguments on volume fraction, diffusivity and 19F 
concentration in a three-compartment model of the labyrinth, the maternal blood pool is the dominating source 
of MR  PO2 signal.
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lives or complex response of  T1 to  PO2 (Perfluorodecalin). Based on a recent comparison of PFCs for preclini-
cal  research51, we decided to use Perfluoro-15-crown-5-ether since this compound has a strong, narrow single 
resonance from 20 magnetically equivalent 19F nuclei per molecule and a very long half life in blood, allowing 
long imaging times in a biologically stable state. For oxygenation imaging, the response of PFCE relaxation rate 
 R1 to changes in  PO2 follows a simple linear relationship and the slope is in the medium/upper range compared 
to other  compounds52. However, the extremely long half live in the  liver51 limits the use of this compound to 
preclinical animal studies. In addition, it needs to be determined if the 19F agent has any undesired effect on 
fetuses. Generally, PFCs are biologically inert and very well tolerated by the body even in high doses. For adults, 
safety of high doses of i.v. injected PFC emulsions similar to the one used in this study, have been confirmed in 
clinical studies. Future improvements in SNR, pulse sequences for complex  spectra53 and shortening of imaging 
times will enable the use of clinically more favorable PFCs such as PFOB, which has a similarly strong 1/T1 to 
 PO2 response for the  CF3 group (unpublished in vitro data). Further improvement include the use of higher con-
centrated emulsions in order to increase SNR and PEGylation of particles to prolong systemic circulation  time54.
Conclusion
Combining advances in small animal MRI hardware and 19F agent synthesis, this study presents the first impor-
tant step in using 19F MRI for placental phenotyping. Detection of decreased  PO2 in Lgals1deficient mice high-
lights the potential of the technique in a mouse model of preeclampsia, one of the most detrimental pregnancy 
complications. We foresee two important use cases of placental oxygenation 19F MRI. First, it presents a screening 
method in animal models of placental malfunction, especially when oxygenation is a primary outcome measure 
and is uncoupled from surrogate markers such as perfusion or blood oxygenation  SO2. Second, since 19F MRI 
provides absolute values of  PO2, it bears potential to calibrate less invasive techniques based on conventional 1H 
measurements such as BOLD/TOLD  MRI55. This is the first study to characterize placental oxygenation in vivo 
during uneventful pregnancy and a pathological disorder such as preeclampsia using 19F MRI.
Methods
Animals. Inbred 129/P3J lectin, galactoside-binding, soluble, 1 (Lgals1) wildtype (WT) and deficient (KO) 
mice were maintained in our animal facility with a 12L/12D  cycle35. Eight- to 10-week-old virgin female Lgals1 
WT or KO mice were mated with 8- to 14-week-old Lgals1 WT or KO males respectively. Females were inspected 
daily for vaginal plugs; sighting a vaginal plug was designated as day 0 of pregnancy. Pregnant Lgals1 WT (nor-
mal pregnancy,  nm = 3 mothers/np = 19 placentas) or KO (preeclampsia model,  nm = 4/np = 17) female mice were 
subjected to 19F MRI on E14/E15 and the whole implantation units were harvested to investigate the presence of 
contrast dye in the placenta circulation. Animals were scanned in order of breeding, no additional randomiza-
tion was performed. All experimental protocols were approved by Charité and the state authority for Animal Use 
in Research and Education Berlin committee under license G0286/16.
Perfluorocarbon emulsion. PFCE emulsions were prepared using 2.4% (w/w) phospholipid (Lipoid E80S, 
Lipoid AG, Ludwigshafen, Germany), 0.5 mol% Rhodamine-DHPE (Lissamine Rhodamine B 1,2-Dihexade-
canoyl-sn-Glycero-3-Phosphoethanolamine, Triethylammonium Salt, Thermo Fisher Scientific, Waltham, MA, 
USA) dissolved in 10 mM phosphate buffer (7 mM  Na2HPO4, 3 mM  NaH2PO4, pH 7.4 isotonized with 2.5% 
(w/w) glycerol) and mixed for 30 min. Next, 40% (w/w) PFCE (ABCR, Karlsruhe, Germany) was added to the 
dispersion and a crude emulsion was formed by high shear mixing (Ultra Turrax TP 18/10; IKA-Werke, Staufen, 
Germany). Finally, high shear homogenization was performed in 10 cycles at 1000 bar using a LV1 microfluid-
izer (Microfluidics Corp, Westwood, MA, USA).
MRI. MRI was performed at 7  T on a Bruker BioSpec 70/20 (Bruker BioSpin, Ettlingen, Germany) with 
Paravision 6.0.1 software using a double-tuned 1H/19F 40 mm diameter transmit/receive volume coil (Bruker). 
Anesthesia was initiated with 2–3% isoflurane and maintained using 1.5–2% isoflurane in a 30%/70% mixture 
of  O2/N2O. To allow i.v. injections during MRI, a catheter was surgically placed in the femoral vein and the ani-
mal was positioned in supine position on an animal cradle. The head was placed in the anesthesia mask with a 
toothbar. Extremities were gently fixed with adhesive tape to stretch the animal and reduce abdominal motion. 
An MRI-compatible small animal monitoring system was used to monitor respiration and temperature (SA 
instruments, Stony Brook, NY, USA). Temperature was maintained at 37 ± 0.5  °C using a rectal temperature 
probe linked to a warm-water-driven feedback-controlled blanket. Respiration was monitored with a pressure-
sensitive pad placed underneath the back of the animal.  T2-weighted anatomical images were acquired using a 
1H 2D respiration-triggered rapid acquisition with relaxation enhancement (RARE) sequence with field-of-view 
(FOV) = 39.2  mm × 51.2  mm, image matrix (MTX) = 196 × 256, slice thickness 1  mm, 20 coronal slices with 
0.2 mm gap between adjacent slices, fat suppression, repetition time (TR) = 1.6 s, RARE factor = 8, echo time 
distance (ΔTE) = 8 ms, effective echo time (TE) = 16 ms, readout bandwidth (BW) = 50 kHz, number of averages 
(NA) = 6, time of acquisition (TA) = 3:50  min, effective TA including dead time due to triggering = 5–7  min. 
400 µL PFCE emulsion were injected very slowly i.v. over 10 min and the system was switched to 19F. The basic 
frequency was calibrated to the PFCE frequency at around − 26 kHz from the scanner software standard 19F 
frequency using a free induction decay experiment (SINGLEPULSE, bandwidth BW = 3  kHz, TR = 110  ms, 
NA = 500, TA = 55  s). The reference pulse gain was copied from the 1H acquisition since this parameter was 
similar for 1H and 19F channels of the double-tuned birdcage coil as tested in a separate in vitro experiment on 
a tube with the pure PFCE emulsion. 19F T1 weighted images were acquired using a non-triggered, saturation 
recovery 2D RARE pulse sequence (FOV = 39.2 mmx51.2 mm, MTX = 64 × 84, 8 coronal slices with 0.4 mm 
gap, 2 mm slice thickness, multiple TRs of  TR1 = 318 ms/TR2 = 719 ms/TR3 = 1398 ms/TR4 = 5000 ms, RARE 
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factor = 2, ΔTE = TE = 14.3 ms, BW = 10 kHz, NA = 5, TA = 19:50 min). A narrow excitation and refocusing pulse 
bandwidth (1 kHz) was chosen to avoid chemical shift artefacts from isoflurane signal. In order to transfer ana-
tomical volumes of interest (VOI) from the anatomical 1H scan to the 19F T1 weighted images, the center and 
orientation of both slice stacks were identical.
Each time after changing breathing gas  O2 levels, we allowed > 10 min until the center of k-space of the 19F 
scans in order to ensure an equilibrium of blood gases including a 5 min resting period and the 5–7 min during 
1H MRI acquisition (Fig. 1).
MRI  PO2 analysis. MRI analysis was performed blinded to the genotype of animals. To reduce the impact 
of noise,  T1 weighted images were preprocessed in ImageJ (v1.52a, https ://image j.nih.gov) using the following 
steps:
1. Voxel-wise conversion of signal intensity into SNR. In order to mitigate impact of non-Gaussian noise dis-
tribution in low SNR magnitude images, we used the approximation by Gudbjartsson and  Patz56
with magnitude signal intensity on the original image SIm. The noise in magnitude images σm was measured 
as the standard deviation of SIm in a region of interest with no signal and Gaussian noise was calculated via
2. Bicubic linear interpolation to the 1H image resolution
3. Gaussian blur filtering using 3 pixel kernel width
4. Exclusion of all voxels with an SNR < 5 on the TR = 5 s image from all further analysis
Volumes of interest of each placenta were drawn on 1H anatomical MR images using ITK Snap (v. 3.6.0, http://
www.itksn ap.org)57 and transferred to the preprocessed 19F SNR maps. Mean 19F SNR was measured for each TR 
and exported into MATLAB (version R2014b, MathWorks, Natick, USA). The relaxation time  T1 of the placenta 
was calculated by fitting the saturation recovery signal model
The fitted equilibrium signal  S0 is proportional to the 19F concentration and was analyzed separately.  PO2 was 
calculated using the in vitro calibration of a previous  study21
Histology. At the end of the MRI acquisition, pregnant mice received 100 µL DyLight 488 Labeled Lyco-
persiconEsculentum (Tomato) Lectin (LEL, TL, Vector Laboratories, BiozolDiagnostica) dissolved in 100 µL 
PBS i.v. over 5 min. Animals were euthanized by cervical dislocation. The entire pregnant uterine horns were 
dissected and first rinsed in 0.1 M PBS, cryoprotected in Tissue-Tek (VWR), frozen and kept at − 80 °C until 
processing. Serial cryosections from whole implantations on E14/E15 were cut at 8 μm. The slides were washed 
in TBS for 5 min and nuclei in all sections were counterstained by incubating 5 min in DAPI solution, followed 
by washing and mounting in ProLong Gold (Invitrogen, Thermo Scientific; 99-904-02). Sections were analyzed 
using a Pannoramic Digital Slide Scanners MIDI microscope (3DHistech).
Statistics. Mean SNR(TRi) (i = 1, 2, 3, 4), i.e. one value for each of the four preprocessed 19FT1-weighted 
images,  T1 relaxation time,  PO2 and  S0 in the placenta were statistically evaluated in SPSS (v. 25.0., IBM Corp., 
Armonk/NY, USA). Mothers were assumed to be the statistically independent unit, i.e. the analysis of placen-
tas was corrected for nesting. Linear mixed-effects modeling (SPSS MIXED) was used with genotype as the 
between factor and percent oxygen in breathing air as a within factor. Fixed effects of genotype, percent oxy-
gen and their interaction were analyzed. Significant interaction effects were further investigated for an effect of 
genotype using post-hoc linear mixed model for each level of percent oxygen. Significant effects were further 
investigated using unpaired two-tailed t-tests. Each parameter of interest was treated independently without 
post-hoc correction between parameters.
Data availability
Work instructions, MRI raw data, processed data used for calculating  PO2 and detailed statistical output can be 
found on https ://doi.org/10.5281/zenod o.38762 71.
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